Ashvattha Therapeutics Funding & Investors
Redwood City, CA
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.
avttx.comTotal Amount Raised: $148,000,000
Ashvattha Therapeutics Funding Rounds
Series B
$50,000,000
Series B Investors
Tribe CapitalNatural CapitalSeries B
$69,000,000
Series B Investors
Huadong MedicineNatural Capital Investment FundTribe CapitalPlum AlleyConvertible Note
$22,000,000
Convertible Note Investors
Natural CapitalSam AltmanPhilip DeutchBhaskar GhoshKyle WangKingsley AdvaniSakya DuvvuruHelios CapitalPlum AlleyTribe CapitalSand Hill AngelsZephyr Venture PartnersSeries A
$7,000,000
Series A Investors
Natural CapitalEcoR1 CapitalArjun Sethi
Funding info provided by Diffbot.